Literature DB >> 19290478

Shedding light on DARC: the role of the Duffy antigen/receptor for chemokines in inflammation, infection and malignancy.

K Horne1, Ian J Woolley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19290478     DOI： 10.1007/s00011-009-0023-9

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  38 in total

1.  The human Duffy antigen binds selected inflammatory but not homeostatic chemokines.

Authors:  Lucy Gardner; Angela M Patterson; Brian A Ashton; Michael A Stone; Jim Middleton
Journal:  Biochem Biophys Res Commun       Date:  2004-08-20       Impact factor: 3.575

2.  Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants.

Authors:  L H Miller; S J Mason; J A Dvorak; M H McGinniss; I K Rothman
Journal:  Science       Date:  1975-08-15       Impact factor: 47.728

3.  Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood-stage infection.

Authors:  P Michon; I Woolley; E M Wood; W Kastens; P A Zimmerman; J H Adams
Journal:  FEBS Lett       Date:  2001-04-20       Impact factor: 4.124

4.  Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism.

Authors:  C Tournamille; C Le Van Kim; P Gane; J P Cartron; Y Colin
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

5.  Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction.

Authors:  M Wadhwa; M J Seghatchian; P Dilger; M Contreras; R Thorpe
Journal:  Transfus Sci       Date:  2000-08

6.  Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein.

Authors:  P Michon; T Fraser; J H Adams
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  The association of pre-eclampsia with the Duffy negative phenotype in women of West African descent.

Authors:  Francien V Velzing-Aarts; Fey P L van der Dijs; Frits A J Muskiet; Ashley J Duits
Journal:  BJOG       Date:  2002-04       Impact factor: 6.531

8.  Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.

Authors:  Weijing He; Stuart Neil; Hemant Kulkarni; Edward Wright; Brian K Agan; Vincent C Marconi; Matthew J Dolan; Robin A Weiss; Sunil K Ahuja
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

9.  High serum interleukin-8 levels in afro-caribbean women with pre-eclampsia. Relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor.

Authors:  Francien V Velzing-Aarts; Frits A J Muskiet; Fey P L van der Dijs; Ashley J Duits
Journal:  Am J Reprod Immunol       Date:  2002-11       Impact factor: 3.886

10.  Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.

Authors:  Linda W Horton; Yingchun Yu; Snjezana Zaja-Milatovic; Robert M Strieter; Ann Richmond
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701
View more
  17 in total

1.  CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection.

Authors:  Junjie Mei; Yuhong Liu; Ning Dai; Michael Favara; Teshell Greene; Samithamby Jeyaseelan; Mortimer Poncz; Janet S Lee; G Scott Worthen
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

2.  Identification of the tetraspanin CD82 as a new barrier to xenotransplantation.

Authors:  Soad M Saleh; Ranjit S Parhar; Reem S Al-Hejailan; Razan H Bakheet; Hala S Khaleel; Hanif G Khalak; Anason S Halees; Marya Z Zaidi; Brian F Meyer; Gisella P Yung; Jörg D Seebach; Walter Conca; Khalid S Khabar; Kate S Collison; Futwan A Al-Mohanna
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

Review 3.  Molecular basis of the Duffy blood group system.

Authors:  Gabriela Höher; Marilu Fiegenbaum; Silvana Almeida
Journal:  Blood Transfus       Date:  2017-01-30       Impact factor: 3.443

4.  Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice.

Authors:  Wuzhou Wan; Qian Liu; Michail S Lionakis; Ana Paula M P Marino; Stasia A Anderson; Muthulekha Swamydas; Philip M Murphy
Journal:  Cardiovasc Res       Date:  2015-04-08       Impact factor: 10.787

5.  Distribution of Duffy Antigen Receptor for Chemokines (DARC) and Risk of Prostate Cancer in Barbados, West Indies.

Authors:  Barbara Nemesure; Suh-Yuh Wu; Anselm Hennis; M Cristina Leske
Journal:  J Immigr Minor Health       Date:  2015-06

6.  Host chemokines bind to Staphylococcus aureus and stimulate protein A release.

Authors:  Sunny C Yung; David Parenti; Philip M Murphy
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

Review 7.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

8.  Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).

Authors:  Amanda Maestre; Carlos Muskus; Victoria Duque; Olga Agudelo; Pu Liu; Akihide Takagi; Francis B Ntumngia; John H Adams; Kim Lee Sim; Stephen L Hoffman; Giampietro Corradin; Ivan D Velez; Ruobing Wang
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

9.  The global distribution of the Duffy blood group.

Authors:  Rosalind E Howes; Anand P Patil; Frédéric B Piel; Oscar A Nyangiri; Caroline W Kabaria; Peter W Gething; Peter A Zimmerman; Céline Barnadas; Cynthia M Beall; Amha Gebremedhin; Didier Ménard; Thomas N Williams; David J Weatherall; Simon I Hay
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

10.  IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.

Authors:  Claudia Brehm; Sabine Huenecke; Andrea Quaiser; Ruth Esser; Melanie Bremm; Stephan Kloess; Jan Soerensen; Hermann Kreyenberg; Christian Seidl; Petra S A Becker; Heiko Mühl; Thomas Klingebiel; Peter Bader; Jakob R Passweg; Dirk Schwabe; Ulrike Koehl
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.